208 - PIDS/ESPID: Pediatric Tuberculosis - Latest News

Saturday, October 22, 2022

10:30 AM – 11:45 AM US ET

Location: 146 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

C. Buddy Creech, MD, MPH

Professor
Vanderbilt Vaccine Research Program
Vanderbilt University Medical Center
Nashville, TN, United States

Disclosure(s): No financial relationships to disclose
Vana Spoulou, MD, MPhil, PhD (she/her/hers)

Professor Paedaitric Infectious DIseases
National and Kapodistrian University of Athens
GOUDI, Greece

Disclosure(s): No financial relationships to disclose

Faculty(s)

Anna Mandalakas, MD, PHD

Professor
Baylor College of Medicine
Houston, TX, United States

Disclosure(s): Janssen Scientific Affairs, LLC: member of DSMB (Ongoing); Oxford Immunotech: Honoraria (Terminated)

Slides
Anna Turkova, MD

Clinical Consultant - Principal Research Fellow
Institute of Clinical Trials & Methodology
London, United Kingdom

Disclosure(s): Viiv Healthcare: Advisory board (Terminated)

Slides
Nigel Curtis, FRCPCH, PhD (he/him/his)

Professor of Paediatric Infectious Diseases & Head of Infectious Diseases
Royal Children's Hospital Melbourne & University of Melbourne
Parkville, Victoria, Australia

Disclosure(s): No financial relationships to disclose
AS

Andrew Steenhoff, MBBCh, DCH

Attending Physician/Medical Director, Global Health Center
Pediatrics
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States

Disclosure(s): No financial relationships to disclose

Slides
Elizabeth Schlaudecker, MD, MPH

Associate Professor of Pediatrics
Department of Pediatrics
University of Cincinnati College of Medicine
Cincinnati, Ohio, United States

Disclosure(s): Pfizer, Inc.: Grant/Research Support (Ongoing); Sanofi Pasteur Inc.: Advisor/Consultant (Ongoing)

Disclosure(s):

C. Buddy Creech, MD, MPH: No financial relationships to disclose

Vana Spoulou, MD, MPhil, PhD: No financial relationships to disclose

Anna M. Mandalakas, MD, PHD: Janssen Scientific Affairs, LLC: member of DSMB (Ongoing); Oxford Immunotech: Honoraria (Terminated)

Anna Turkova, MD: Viiv Healthcare: Advisory board (Terminated)

Nigel Curtis: No financial relationships to disclose

Andrew Steenhoff, MBBCh, DCH: No financial relationships to disclose

Elizabeth P. Schlaudecker, MD, MPH: Pfizer, Inc.: Grant/Research Support (Ongoing); Sanofi Pasteur Inc.: Advisor/Consultant (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the current global epidemiology of pediatric tuberculosis in the context of both Europe and the United States;
discuss past, current and future technologies for diagnosing and treating pediatric tuberculosis;
define challenges associated with creating an effective vaccine against tuberculosis from a historical and prospective perspective

Presentations:

10:30 AM – 11:00 AM US ET

Epidemiology, Diagnosis and Treatment of Pediatric Tuberculosis
Speaker: Anna Turkova, MD – Institute of Clinical Trials & Methodology
Speaker: Anna M. Mandalakas, MD, PHD – Baylor College of Medicine
11:00 AM – 11:30 AM US ET

Historical Perspective and Promising Prospects: Why Is a Good TB Vaccine So Hard?
Speaker: Andrew Steenhoff, MBBCh, DCH – Children's Hospital of Philadelphia
Speaker: Nigel Curtis, FRCPCH, PhD (he/him/his) – Royal Children's Hospital Melbourne & University of Melbourne
11:30 AM – 11:45 AM US ET

Discussion
Speaker: Elizabeth P. Schlaudecker, MD, MPH – University of Cincinnati College of Medicine